• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    1.58 Sep 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:1.58
    Open:N/A
    Bid:1.56 x 7000
    Ask:1.58 x 5000
    1y Target Est:5.50
    Beta:1.10441
    Earnings Date:Oct 27 - Nov 2 (Est.)
    Day's Range:N/A - N/A
    52wk Range:1.50 - 2.94
    Volume:0
    Avg Vol (3m):2,226,740
    Market Cap:285.44M
    P/E (ttm):N/A
    EPS (ttm):-0.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTIC 0.00%285.44M
    BMY99.40B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.53
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.44
    Quarterly EPS Est (Sep-15) :-0.09
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback